Searched for
OXFORD ASTRAZENECA
Serum Institute of India to manufacture Oxford Ebola vaccine backed by $8.6 million CEPI fundingSerum Institute of India will produce clinical trial doses of a new Ebola vaccine from Oxford University. This initiative is backed by fres...- Moderna and other groups get $60 million to develop Ebola vaccineCEPI is investing around $60 million to speed up the creation of vaccines against the deadly Ebola Bundibugyo virus. This funding will supp...
- What to know about the Bundibugyo virus, a species of Ebola causing an outbreak in CongoA rare Bundibugyo virus outbreak in Congo, with over 200 deaths, lacks specific treatments or vaccines, complicating response efforts. Whil...
- AstraZeneca jab uncertainty will hit Oxford BioMedica’s revenueIn a recent report, Oxford Biomedica warned that uncertainty surrounding AstraZeneca’s Covid-19 contract will bring reduction in earnings t...
- AstraZeneca hits snag in Covid drug developmentThe drug, made from a combination of two antibodies, failed its main goal to treat Covid-19 symptoms in exposed patients, AstraZeneca said ...
- EU regulator advices against second AstraZeneca shot in those with blood clotsThe advice for healthcare professionals was provided by the European Medicines Agency (EMA) as part of an ongoing review into rare, but sev...
- Two AstraZeneca COVID shots could be 85-90% effective, UK real-world data suggestPHE said the preliminary findings were the first of its kind on the effectiveness of two doses of AstraZeneca in a real-world setting but c...
- Two AstraZeneca Covid shots 85-90% effective: UK real-world analysisTwo doses of the Oxford/AstraZeneca Covid-19 vaccine are around 85% to 90% effective against symptomatic disease, Public Health England (PH...
- UK scientists find higher risk of brain clots from COVID-19 compared with vaccinesA study of 500,000 COVID-19 patients found CVST had occurred at a rate of 39 people out of a million following infection, researchers said....
- Sri Lanka temporarily suspends COVID-19 jabs due to delay in securing vaccines from SII: MinisterSri Lanka launched its inoculation programme in late January when India gifted 500,000 doses of Oxford-AstraZeneca. Till Thursday 913,219 p...
- SII seeks Government's nod to give 50 lakh Covishield doses to UK, says won't affect India's vaccination driveIn a communique to Union Health Secretary Rajesh Bhushan on Tuesday, the Director of Government and Regulatory Affairs at the Pune-based Se...
- UK PM Boris Johnson says he will get Oxford/AstraZeneca COVID-19 vaccine very soonBritish Prime Minister Boris Johnson said on Wednesday he would get the Oxford/AstraZeneca COVID-19 shot very soon, voicing his confidence ...
- UK to receive 10 million AstraZeneca doses from Serum InstituteSII, the world’s largest vaccine manufacturer by volume, is mass producing the AstraZeneca vaccine, developed with Oxford University, for d...
- Britain approves AstraZeneca/Oxford COVID-19 vaccineRegulatory endorsement is a welcome boost for AstraZeneca and the Oxford team, which have been accused of a lack of clarity about the resul...
- AstraZeneca's Covid-19 vaccine has a 'winning formula': Chief executive Pascal SoriotThe UK government announced on December 23 that the developers of the Oxford AstraZeneca vaccine had submitted their data to the Medicines ...
- Oxford/AstraZeneca in ‘mix-match' COVID-19 vaccine trial with Russia's SputnikThe two sets of experts are to join forces to explore if a combination of the two jabs, both using a benign virus called adenovirus, could ...
- Will resume COVID-19 vaccine trials after DCGI nod: Serum InstitutePharma giant AstraZeneca on Saturday said that clinical trials for the AstraZeneca Oxford coronavirus vaccine, AZD1222, have resumed in the...
- Oxford, AstraZeneca COVID-19 vaccine trials resume days after pauseThe study had been previously stopped in July for several days after a participant who got the vaccine developed neurological symptoms; it ...
- Serum Institute of India officially halts the trial of Astrazeneca-Oxford vaccine in India"We are reviewing the situation and pausing India trials till AstraZeneca restarts the trials. We are following DCGI's instructions and wil...
- India trials of COVID-19 vaccine is going on: Serum InstituteLast month, the Drug Controller General of India had granted permission to the Pune-based SII to conduct Phase-II and -III human clinical t...
Load More
